SLS Chart
- 52-Week Range: $2.14 - $13.71
- Market Capitalization: $64.07M
- Short Percentage: 0%
- Target Price: $12.25
- Shares Outstanding: 20.54M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
SLS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- SELLAS Life Sciences Launches Expanded Access Program for Galinpepimut-SGlobeNewsWire | April 26th
- SELLAS Life Sciences Provides Business Update and First Quarter 2022 HighlightsGlobeNewsWire | April 5th
- SELLAS Life Sciences Announces Pricing of $25.0 Million Underwritten Public OfferingGlobeNewsWire | March 31st
- Sellas Life Sciences Shares Jump As China Approves Galinpepimut IND For Blood CancerBenzinga | January 27th
- SELLAS Life Sciences Announces IND Acceptance for First Clinical Trial of GPS in ChinaGlobeNewsWire | January 26th
- SELLAS Life Sciences Promotes John Burns to Senior Vice President, Finance and Chief Accounting OfficerGlobeNewsWire | January 5th
- SELLAS Life Sciences Announces Final Court Approval of Settlement of Derivative LitigationGlobeNewsWire | November 23rd
- SELLAS Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire | November 12th
Company Info
Website: https://www.sellaslifesciences.com
Address: Times Square Tower, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 11
Address: Times Square Tower, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 11
$SLS eyeing for a scalp
$SLS shorting it
$SLS Let’s get it
$SLS the future is so bright .. I gotta wear shades..
$SLS wtf is going on?
$SLS to the moon!
$SLS I do it for the thrills!
$SLS When they tell me diversifying is for idiots
$SLS Looks like a solid reversal - retesting support right now
definitely thinking about swinging this